COPD treatment

COPD executive care team cuts readmission rate in halfThe COPD executive care team at Sanford Medical Center is leading to impressive results. Find out who is part of the team and how it works.
Stem cell therapy shows promise for COPD, but questions remainAutologous stem cell therapy may offer hope for patients with COPD. But some say caution is necessary.
‘Encouraging’ COPD drug pipeline could ease symptoms, address root causesAlbert A. Rizzo, MD, senior medical advisor for the American Lung Association, says the increasing number of drugs in the pipeline could improve airflow address the underlying disease process.
Top factors that predict 30-day COPD readmissionsRecent study findings reveal which patients are more likely to be readmitted for COPD problems, and which readmission reduction strategies might work best.
Long-term safety of glycopyrrolate: A randomized study of COPD patientsGlycopyrrolate bromide is a quick-onset long-acting muscarinic antagonist bronchodilator with FDA approval for use as maintenance treatment of COPD. Seebri Neohaler is approved for use at a dose of 15.6 ug inhaled twice daily.
Benzodiazepine use in older COPD patients may not be idealBenzodiazepine use in COPD patients linked to increased exacerbation, according to study out of Canada.
Health apps beneficial to help prevent COPD exacerbationA new report indicates the successes of early interventions through digital health applications to help manage COPD.
Smoke-free rules can help shield kids from COPDResearchers encourage smoke-free rules in homes, private cars, and outdoor children's play areas to help prevent and reduce long-term burden of COPD
Physical activity decreases over time in COPD patientsA new study finds that patients with COPD experience a decrease in physical activity over time, leading to further physical decline.
Large-scale COPD patient network in the worksA large chronic obstructive pulmonary disease (COPD) patient network is in the works.